drugset / Trial / NCT00003893

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

NCT00003893

Phase 3 Completed 2250 enrolled University Hospital Birmingham
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumors cells. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known which regimen of chemotherapy plus radiation therapy is more effective for early-stage breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of adjuvant chemotherapy plus radiation therapy in treating women who have early-stage breast cancer.

Timeline

Start
1998-07
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified
Subject Doxorubicin Other / unclassified
Subject Epirubicin Small molecule
Subject Methotrexate Small molecule
Subject Mitomycin C Other / unclassified
Subject Mitoxantrone Small molecule
Subject fluorouracil Small molecule